CAH
Income statement / Annual
Last year (2024), Cardinal Health, Inc.'s total revenue was $226.83 B,
an increase of 10.64% from the previous year.
In 2024, Cardinal Health, Inc.'s net income was $852.00 M.
See Cardinal Health, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
06/30/2015 |
| Operating Revenue |
$226.83 B
|
$205.01 B
|
$181.36 B
|
$162.47 B
|
$152.92 B
|
$145.53 B
|
$136.81 B
|
$129.98 B
|
$121.55 B
|
$102.53 B
|
| Cost of Revenue |
$219.41 B |
$198.12 B |
$174.82 B |
$155.69 B |
$146.05 B |
$138.70 B |
$129.63 B |
$123.43 B |
$115.00 B |
$96.82 B |
| Gross Profit |
$7.41 B |
$6.89 B |
$6.55 B |
$6.78 B |
$6.87 B |
$6.83 B |
$7.18 B |
$6.54 B |
$6.54 B |
$5.71 B |
| Gross Profit Ratio |
0.03 |
0.03 |
0.04 |
0.04 |
0.04 |
0.05 |
0.05 |
0.05 |
0.05 |
0.06 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$4.60 B
|
$3.78 B
|
$3.65 B
|
$3.24 B
|
| Selling & Marketing
Expenses |
$5.00 B
|
$4.83 B
|
$0.00
|
$4.53 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$5.00 B
|
$4.83 B
|
$4.56 B
|
$4.53 B
|
$4.57 B
|
$4.48 B
|
$4.60 B
|
$3.78 B
|
$3.65 B
|
$3.24 B
|
| Other Expenses |
$0.00 |
$4.00 M |
$324.00 M |
$451.00 M |
$524.00 M |
$621.00 M |
-$23.00 M |
$5.00 M |
-$5.00 M |
$7.00 M |
| Operating Expenses |
$5.00 B |
$5.12 B |
$4.88 B |
$4.98 B |
$5.10 B |
$5.10 B |
$5.30 B |
$4.30 B |
$4.11 B |
$3.52 B |
| Cost And Expenses |
$224.67 B |
$203.24 B |
$179.70 B |
$160.67 B |
$151.15 B |
$143.80 B |
$134.93 B |
$127.73 B |
$119.11 B |
$100.34 B |
| Interest Income |
$0.00 |
$93.00 M |
$149.00 M |
$180.00 M |
$238.00 M |
$294.00 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$51.00 M |
$93.00 M |
$149.00 M |
$180.00 M |
$238.00 M |
$294.00 M |
$329.00 M |
$201.00 M |
$178.00 M |
$141.00 M |
| Depreciation &
Amortization |
$710.00 M
|
$692.00 M
|
$723.00 M
|
$805.00 M
|
$917.00 M
|
$986.00 M
|
$1.02 B
|
$709.00 M
|
$632.00 M
|
$451.00 M
|
| EBITDA |
$1.98 B
|
$1.44 B
|
$126.00 M
|
$1.31 B
|
-$2.62 B
|
$3.03 B
|
$1.12 B
|
$2.83 B
|
$3.09 B
|
$2.56 B
|
| EBITDA Ratio |
0.01 |
0.01 |
0.01 |
0.02 |
0.02 |
0.02 |
0.02 |
0.02 |
0.03 |
0.03 |
| Operating Income Ratio
|
0.01
|
0
|
0.01
|
0.01
|
0.01
|
0.01
|
0
|
0.02
|
0.02
|
0.02
|
| Total Other
Income/Expenses Net |
-$42.00 M
|
-$89.00 M
|
-$173.00 M
|
-$149.00 M
|
$326.00 M
|
$18.00 M
|
-$2.21 B
|
-$196.00 M
|
-$144.00 M
|
-$232.00 M
|
| Income Before Tax |
$1.20 B |
$638.00 M |
-$769.00 M |
$323.00 M |
-$3.77 B |
$1.75 B |
-$228.00 M |
$1.92 B |
$2.28 B |
$1.97 B |
| Income Before Tax Ratio
|
0.01
|
0
|
-0
|
0
|
-0.02
|
0.01
|
-0
|
0.01
|
0.02
|
0.02
|
| Income Tax Expense |
$348.00 M |
$376.00 M |
$163.00 M |
-$289.00 M |
-$79.00 M |
$386.00 M |
-$487.00 M |
$630.00 M |
$845.00 M |
$755.00 M |
| Net Income |
$852.00 M |
$261.00 M |
-$932.00 M |
$611.00 M |
-$3.69 B |
$1.36 B |
$256.00 M |
$1.29 B |
$1.43 B |
$1.22 B |
| Net Income Ratio |
0 |
0 |
-0.01 |
0 |
-0.02 |
0.01 |
0 |
0.01 |
0.01 |
0.01 |
| EPS |
3.48 |
1 |
-3.34 |
2.09 |
-12.6 |
4.54 |
0.82 |
4.06 |
4.36 |
3.66 |
| EPS Diluted |
3.45 |
1 |
-3.34 |
2.08 |
-12.6 |
4.53 |
0.81 |
4.03 |
4.32 |
3.62 |
| Weighted Average Shares
Out |
$245.00 M
|
$261.00 M
|
$279.00 M
|
$292.00 M
|
$293.00 M
|
$300.00 M
|
$313.00 M
|
$317.00 M
|
$327.00 M
|
$332.00 M
|
| Weighted Average Shares
Out Diluted |
$247.00 M
|
$262.00 M
|
$279.00 M
|
$294.00 M
|
$293.00 M
|
$301.00 M
|
$315.00 M
|
$320.00 M
|
$330.00 M
|
$335.00 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
